Oral Cavity Serves as Long-Term COVID-19 Reservoir with Increased Periodontal and Viral Disease Risk:
-COVID-19 history significantly correlates with severe oral health complications while vaccination reduced but did not eliminate these issues. 1/
A NEW study identified oral associated #LonhCovid primarily manifested as periodontal (gum) disease (COVID +ve: 73.1±18.9% vs COVID -ve: 33.1±14.3%)
Covid19 positive cases correlated w/ higher rates of dry mouth (57.5%), taste disturbance (47%) & smell loss (20%). 2/
Vaccination reduced oral LongCovid (PASC) in COVID-19 positive subjects; however, periodontal disease indicators persisted compared to the COVID-19 negative group. 3/
Notably, 3-6 months post-infection, while SARS-CoV-2 Spike (S) transcript was rarely detected in saliva (∼6%), its protein was commonly detected (∼70%) in the COVID-19 positive subjects indicating incomplete viral clearance. 4/
This correlates with significantly higher salivary expression of viral entry receptors (ACE2, and TRMPSS2), and inflammatory mediators (IL-6, IL-8 and MMP-8), in COVID-19 positive subjects. 5/
This finding was further supported by higher prevalence of other oral viruses including Epstein-Barr Virus (70.5%), Herpes Simplex Virus (8.1%), and Human Papillomavirus (17.5%) in COVID-19 positive subjects. 6/6
In efforts to comprehend this complex disorder, recent research on #LongCOVID has illuminated its prevalence, causes, and management techniques. Even today, studies are still investigating the long-term effects of SARS-CoV-2 infection on numerous organ systems. 1/
A review of 180 studies suggests that LongCOVID symptoms like memory problems, poor concentration, & brain fog may be driven by self-sustaining feedback loops involving vascular dysfunction, neuroinflammation & gut-brain axis disruption 2/
Recent study shows that patients with long COVID or similar conditions like ME/CFS often exhibit an enlarged hippocampus compared to healthy individuals, potentially linking brain inflammation to cognitive challenges. 3/
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache & depression. Recent study shows that in #LongCOVID, IFN-y production persists until symptoms improve, highlighting a potential biomarker & a target for therapies 1/
The study shows that initial infection with SARS-CoV-2 triggers production of the antiviral protein IFN-γ, which is a normal reaction from the immune system. 2/
For most people, when their infection clears, COVID-19 symptoms cease and production of this protein stops, but the researchers found that high levels of IFN-γpersisted in some Long COVID patients for up to 31 months. 3/
A ray of hope for millions of Down syndrome patients!
Gene editing may eventually allow #Trisomy21 to be treated at the cellular level.
Researchers used the CRISPR-Cas9 gene editing system to cleave the 3rd chromosome in previously generated trisomy 21 cell lines 1/
Down syndrome is caused by the presence of a third copy of the 21st chromosome. The condition occurs in approximately 1 in 700 live births and is relatively easy to diagnose at early stages of development. However, there are no treatments. 2/
The researchers used the CRISPR-Cas9 gene editing system to cleave the third chromosome in previously generated trisomy 21 cell linesderived from both pluripotent cells and skin fibroblasts. 3/
According to a NEW study, maternal #Acetaminophen (Paracetamol) exposure during pregnancy may alter placental gene expression leading to a higher likelihood of childhood attention deficit hyperactivity disorder (ADHD) 1/
Researchers analyzed plasma biomarkers of acetaminophen (APAP) exposure in a cohort of 307 African American mother-child pairs. Detection of APAP in second-trimester maternal blood samples correlated with increased odds of ADHD diagnosis in children by age 8–10. 2/
Acetaminophen (also called paracetamol) is widely used during pregnancy, with an estimated 41–70% of pregnant individuals in the United States, Europe, and Asia reporting its use. 3/
A NEW study presents the systematic design of quinoline-containing SARS-CoV-2 papain-like protease (#PLpro) inhibitors as potential oral antiviral drug candidates to treat Covid-19 patients 1/
SARS-CoV-2 main protease (Mpro) inhibitor nirmatrelvir has broad-spectrum antiviral activity against SARS-CoV, MERS-CoV, SARS-CoV-2, and common human coronaviruses HCoV-OC43, 229E, NL63, and HKU1. 2/
Several additional Mpro inhibitors are at different stages of clinical trials, including Pfizer’s second-generation inhibitor PF-07817883 (Ibuzatrelvir) and Merck’s MK-7845 3/
A recent study provides direct evidence for the role of the vagus nerve in gut microbiome-brain communication, addressing a critical gap in the field.
The research demonstrates a clear causal relationship between gut microbiota and vagal nerve activity. 1/
While the vagus nerve has long been thought to facilitate communication between the gut microbiome—the community of microorganisms living in the intestines—and the brain, direct evidence for this process has been limited. 2/
Researchers observed that mice raised without any gut bacteria, known as germ-free mice, exhibited significantly lower activity in their vagus nerve compared to mice with a normal gut microbiome. 3/